Ceribell Named to Fast Company’s 2023 List of the World’s Most Innovative Companies by Seini Moimoi | Mar 2, 2023 | Portfolio News
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants by Seini Moimoi | Feb 21, 2023 | Portfolio News
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 by Seini Moimoi | Feb 16, 2023 | Portfolio News
Vera Therapeutics Releases 36 Week Interim Analysis of Phase 2b Clinical Trial of Atacicept for the Treatment of IgA Nephropathy; Patients in the 150 mg Dose Group Achieved a Delta of 48% Versus Placebo in Mean Reduction in Proteinuria by Seini Moimoi | Jan 30, 2023 | Portfolio News
Cohere Health Introduces Cohere Unify™ Intelligent Prior Authorization by Seini Moimoi | Jan 25, 2023 | Portfolio News
Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD) by Seini Moimoi | Jan 11, 2023 | Portfolio News